Sitemap
Pages
- Cookie Policy
- Dosage Forms
- Home Page
- Lubrizol’s Response to COVID-19
- Markets Served
- Our Story
- Resource Center
- Services
- Analytical Method Development and Validation
- Aseptic Manufacturing
- Biopharmaceutical
- Clinical Drug Product Manufacturing
- Commercial Drug Product Manufacturing
- Dexamethasone-Loaded Silicone for Implantable Systems
- Drug / Device Combination Products
- Drug Product Manufacturing
- Drug Release Testing
- Feasibility Programs
- Formulation
- ICH Stability Programs
- Long Acting
- Micro and Nanotechnology
- Microsphere Feasibility Program for Long-Acting Injectables
- Nanomilling Feasibility Program
- Physical Characterization
- Pre-clinical Drug Product Manufacturing
- Proprietary Technology
- Solubility Improvement and Bioavailability Enhancement
- Stability Indicating Method Development
- Thank You Long Lasting
Resources
- How to Select the Right CDMO for Your Sterile Drug Product
- Solving Bioavailability Challenges Using A Molecule’s Target Product Profile (TPP)
- Bridging Clinical and Commercial Drug Product Manufacturing – Outsourcing Advice from a CDMO
- Parenteral Drug Delivery Trends
- Ocular Implants for Drug Delivery: Improving Patient Outcomes
- Improving Bioavailability & Solubility: Each Molecule Is Unique
- Solubility and Bioavailability Enhancement Techniques
- Nasal Drug Formulation: A Guide to Successful Drug Product Development
- A Guide to Drug Development for Biologics: Overcoming Formulation and Manufacturing Challenges
- 2021 Pharma Trends Shaping the CDMO Industry Outlook – with Barbara Morgan
- Long-Acting Drug Delivery: Injections, Implants, and Combination Products
- Phase Appropriate Filter Validation for Sterile Drug Product Manufacturing
- Filter Validation: Key Elements for Sterile Drug Product Manufacturing
- How Aseptic Nanomilling Can Provide a Solution for Today’s Insoluble Compounds Including HPCs
- A Guide to Solubility Improvement and Bioavailability Enhancement Techniques
- Excipient Selection and Supply for Complex Drug Products
- Molecule to Market Podcast: The Value of Diversity in Pharma
- Incorporation of Dexamethasone Into Silicone Drug-Device Combination Products
- A Pharmaceutical Guide to Cannabis – FAQs for Drug Product Development
- Combination Products for Medical Device Developers
- A Guide to Vaccine Development & Immunization
- Lyophilization of Complex Drug Products: Formulation Challenges and Scale-Up
- Manufacturing Sterile Products
- Improving Bioavailability & Solubility
- Women in Pharma: Reimagining the Glass Ceiling
- The Year That Was and the Year That Will Be
- Ophthalmic Drug Delivery for Retinal Disorders
- Hot Melt Extrusion for Oral Solid Dosage Forms
- The Guide to Analytical Method Development
- Targeted Therapeutics and Nanoparticles
- Optimizing Ophthalmic Drug Delivery for Therapeutic Effectiveness
- Key Takeaways From the FDA Complex Generic Drug Product Development Workshop: Part 2
- Key Takeaways From the FDA Complex Generic Drug Product Development Workshop: Part 1
- Nanomilling: Shaping the Solubility and Bioavailability of Today’s Therapeutics
- Overcoming the Challenges in Drug-Device Combination Product Formulation
- The Demands of the Perfect Dose
- Overcoming Challenges in Ophthalmic Drug Delivery including Bioavailability and Sterility
- Insoluble APIs Scaring You? Don’t Be Afraid of Nanotechnology!
- Implantable Systems and Microparticle Depots Webinar
- Microparticles as Controlled Release Drug Delivery Systems Presentation
- Aseptic Nanomilling Presentation
- Considerations in Particle Sizing – Part 1: Classification of the Various Sizing Techniques
- Code of Federal Regulations Title 21 Part 11 Requirements
- In Vitro Dissolution Testing For Solid Oral Dosage Forms
- How Personalized Medicine is Evolving the CDMO Landscape
- Physical Stability of Disperse Systems
- Drug Substance Solid State Characterization
- Biopharmaceutical Classification System
- Solid Lipid Nanoparticles
- Glossary of Nanotech
- Quality by Design
- Process Analytical Technology
- Phase Behavior of Surface-Active Solutes
- Cubic Phase Particles
- Solid Solutions and Dispersions
- Overview of the Zeta Potential
- Nanotechnology – New Name – Old Science
- Solubility – Ideal Solubility & Solubility Models
- Sampling of Powders
- Potent Compound Handling Operations
- Hot Melt Extrusion
- Emulsion Stability and Testing
- Glossary of Polymer Terms
- Encapsulation
- Mechanical Dispersing of Insoluble APIs
- Dissolution Testing for OSD
- The Patent Process
- Dissolving Films
- Combination Devices
- Surfactants
- Development and Validation of In Vitro Release Testing for Semisolid Formulations
- Emulsions and Emulsifications
- Protein Structure: Primary, Secondary, Tertiary, Quatemary Structures
- Considerations in Particle Sizing – Part 2: Specifying a Particle Size Analyzer
- Analytical Method Development and Validation
- Mass Spectrometry in Bioanalysis
- Skin and Nail: Barrier Function, Structure, and Anatomy Considerations for Drug Delivery
- Particle Size Distribution and Its Measurement
- Lyophilization of Pharmaceuticals: An Overview
- Orphan Drug Product Development: Incentives and Outsourcing Considerations
- Understanding Analytical Method Validation with Laurie Goldman
- The FDA’s Recent Uptick in Ophthalmic NDA & BLA Approvals
- Overcoming Solubility Challenges: Techniques to Improve Dissolution Rate and Increase Bioavailability
- Highly Potent API (HPAPI) Handling: An Expert Interview with Judy Cohen
- Aseptic Manufacturing and Sterile Fill-Finish for Complex Drug Products
- 6 Takeaways from the FDA’s Complex Generic Drug Product Development Workshop
- Hot Melt Extrusion: Solubility Enhancement, Controlled Release, and More
- Why the FDA Loves Complex Generic Drug Products
- Nanomilling: A Key Option for Formulating Water-Insoluble APIs
- What are Complex Drug Products and Why Should You Care?